Hemoglobin Ty gard (αA2β2 124 (H2) Pro → Gln) a stable high O2 affinity variant at the α1β1 contact  by Bursaux, E. et al.
Volume 88, number 1 FEB.5 LETTERS April 1978 
HEMOGLOBIN Ty GARD (&pz 124 (H, ) Pro -+ Gin) 
A stable high O2 affinity variant at the (~~0, contact 
E. BURSAUX, Y. BLOUQUIT*, C. POYART+, J. ROSA*, with the technical assistance of N. AROUS* 
and B. BOHN 
unit& de Recherches INSERM U. 2 7, H6pital Foch, 92150 Suresnes and Cr. 91, * H6pital Henri Mondor, &?teil, France 
Received 10 Ccbruary 1978 
1. Introduction 
In normal HbA the aI/3, contact involves 32 amino 
acid residues equally shared by the a and the /3 chains 
[ 11. Among these contacts only 5 or 6 include a 
hydrogen bond, the remaining bonds being due to van 
der Waals forces [ 11. The similarity of the structure 
of the a,p, contact in oxy and deoxy hemoglobin has 
been reported from X ray crystallography [2], it is in 
contrast to the wide differences observed at the cwJ3~ 
contact between these two quaternary structures. Four- 
teen abnormal hemoglobins have so far been described 
with various substitutions at the cw$, interface [3]. 
Most of these variants were discovered in clinically 
symptom-free patients. In several cases signs of hemo- 
lytic anemia were present [S--8], due to instability 
of these abnormal hemoglobins. Only a few functional 
studies of these abnormal hemoglobins have been 
reported. The aim of this article is to report structural 
and some functional studies of a new high O2 affinity 
mutant at the (Y#~ contact: Hb Ty Card (HbTG): 
c~& 124 (Hz) Pro + Gln, discovered in a polycythemic 
patient. It was silent by routine electrophoresis and 
isolated only by isofocusing electrophoresis. 
2. Material and methods 
Hematological studies were obtained by routine 
Coulter counter analysis. 
Abbreviation: PMB,p-Hydroxymercuribenzoate Na salt (Sig- 
ma, St. Louis, MO) 
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ElsevierlNorth-Holland Biomedical Press 
2.1. Structural studies 
The structural abnormality was determined using 
the following techniques: globin preparation; chain 
separation and characterization; amino ethylation and 
tryptic hydrolysis; analytical and preparative finger 
prints; isolation and purification of large amounts of 
tryptic peptides by ion exchange column chromatog- 
raphy (Beckman M 72, Bio Rad AG 50 X 4 and AG 
1 X 2 resins); amino acid composition of the resulting 
peptides. The sequence of the abnormal peptide was 
determined after manual Edman degradation. The 
methods are in [9]. PMB reacted chains were obtained 
as in [IO]. 
2.2. Functional studies 
Oxygen dissociation curves of washed fresh eryth- 
rocytes were obtained in isotonic phosphate buffer in 
physiological conditions of pH, PC02 at 37°C as in [ 1 I]. 
Functional studies of the purified component were 
done after its separation from HbA and other minor 
components by preparative isoelectrofocusing (LKB 
multiphor, Stockholm) of freshly prepared hemolysate. 
The abnormal Hb was further stripped on ion exchange 
resin to remove the ampholytes and other low molec- 
ular weight contaminants [ 121 and concentrated 
under nitrogen pressure (Aminco system - PM 10 
membrane). O2 binding curves were obtained on 
0.2% Hb4 (tetramer) solutions by the spectrophoto- 
metric equilibrium method in [ 131 in Tris or bis-Tris 
buffer at varying pH values and chloride concentrations 
at 25°C. Methemoglobin content of the purified com- 
ponent never exceeded 4% [ 141. Heat denaturation 
and isopropanol stability tests were done as in [ 151. 
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Purified native HbA stored in liquid nitrogen was used 
as control. 2,3_Diphosphoglycerate (DPG) concentra- 
tions in the fresh red cells were measured as in [ 161. 
3. Results 
The propositus, a 45 year-old man, from the west 
centre of France reported to the laboratory because 
of the recent discovery of a high red cell count from 
routine blood examination (table 1). He was symptom 
free. White cell, platelet and reticulocyte counts were 
normal. No Heinz bodies could be detected in fresh 
erythrocytes. Physical examination did not reveal any 
cardio-pulmonary abnormality. The spleen was not 
enlarged. Blood uric acid was normal. Heat denatura- 
tion and isopropyl alcohol stability tests gave identical 
results relative to purified HbA. Electrophoresis on 
cellulose acetate strips at pH 8.6 of fresh stripped 
hemolysates was identical to that of normal adult 
hemolysates. However, oxygen dissociation curves of 
fresh erythrocytes of the propositus, which are part 
of our screening tests, showed a shift to the left of the 
curve: Pse pH 7.40, PCOa = 40 mm Hg, 37°C = 
20.8 mm Hg compared to the normal adult value of 
26.5 f 0.6 mm Hg. The slope of the Hill plot was 
comparable to that of normal erythrocytes and did 
not indicate the presence of two components (fig.1, 
left panel). [DPG] of the propositus fresh erythro- 
cytes was 0.875 mol/mol Hb4 (Normal controls = 
0.930 f 0.070). Isofocusing electrophoresis in poly- 
acrylamide gels containing 5% ampholytes (LKB, 
Stockholm) revealed two distinct major bands, the 
abnormal one migrating slightly ahead of HbA (pHi 
6.90 compared to 6.95 for HbA). Only one band of 
HbAz was observed indicating that the abnormal 
component was due to a /I chain variant (lig.2). 
3 .l . Structural characterization of the abnormal com- 
ponen t 
The abnormal fl PMB chains could be isolated from 
the oA and flA chains by starch block electrophoresis 
of the PMB-reacted whole hemolysate. PSH globin 
chains were obtained after adding a sufficient amount 
of P-mercaptoethanol to the usual acid-acetone solu- 
tion. Finger prints of the tryptic peptides from the 
amino ethylated (AE) /3 chains were found identical 
to those obtained from AE PA chains. Amino acid 
compositions of all tryptic peptides of the abnormal 
chains were identical to those of normal /IA chains 
except for PT 13. Amino acid content of this peptide 
(table 2) suggested that fl 124 Pro or 0 12.5 Pro were 
substituted by a Cl,. Sequential analysis of /IT 13 
was done to assess the exact nature of the mutation. 
Sufficient amount of this peptide was prepared after 
successive ion exchange chromatographies. From the 
M 72 column the abnormal fl T 13 eluted with the 
same volume of buffer as the PA T 13. By chromatog- 
raphy on an AC X 2 column fix T 13 was eluted after 
PA T 13 and free of /3T .5 and /3T 3 contamination 
(fig.3). The results of the sequential analysis performed 
according to Edman indicated that the actual struc- 
ture of the abnormal /3 chain was /3* (HZ) 124 Pro + Gln. 
3.2. Functional studies of purified Hb Ty Card 
The right panel of fig.1 shows that purified HbTG 
retained the high O2 affinity as observed with the 
erythrocytes and normal cooperativity. Stripped 
Table 1 
Hematological data of the propositus and members of his family 
- 
Generation Age Hb RBC PCV MCV MCH MCHC 
(years) (g/d11 (X lo-‘Z/l) ratio (fu (P& (g/d0 
I.1 (m)a 45 19.2 6.0 54.3 88 31.3 35.8 
I.2 (0 42 14.1 4.6 40.0 87 30.1 35.3 
II.2 (f-J 17 14.5 4.9 39.8 81 29.0 36.4 
II.2 @a 11 14.7 4.8 43.0 89 30.3 34.0 
II.3 (m) 6 13.5 5.0 38.0 75 26.3 35.9 
______ ~~ _____ 
a Carriers of Hb Ty Gard 
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Fig.1: Hill plots of 0, dissociation curves. Left panel: on fresh erythrocytes, in isotonic phosphate bicarbonate buffer at pH 7.40, 
PCO, =4Omm Hgand 37°C. Right panel: on purified Hb solutionsConditions: bis-Tris 0.02 M; [NaCl] 0.005 m; [EDTAI 1O‘6 M; 
pH 7.0; T 25°C; [Hb,] 3 X 10-s M. The inserts show the pH dependence of logP,, in the two conditions. 
Fig.2. Isofocusing electrophoresis in polyacrylamide gels. 
Left: from top to bottom HbA,, HbFII and HbA. Right: 
hemolysate of the propositus with Hb Ty Card. 
Fig.3. Elution profile of a chromatogram of the p Ty Gard 
AE chain tryptic peptides on an AC 1 X 2 resin column. The 
sample was the first peak eluted from a M 72 resin Beckman 
column chromatogram. 
Table 2 
Amino acid composition of peptide p T 13 in HbTG and HbA 
Residue HbTG HbA 
(Found) (ExP.) 
~____ _____ 
Lys 0.80 1.0 
Thr 0.91 1.0 
GlU 3.6 3.0 
Pro 1.16 2.0 
Ala 2.17 2.0 
Val 0.80 1.0 
Tyr 1.05 1.0 
Phe 1.00 -1.0 
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Table 3 
Oxygen binding parameters measured on purified HbTG and HbA 
Hb Ty Gard HbA, 
Additionsa -__ 
lo@,, n loti,, n * (lO@,,A 1 - l”#,,HbTG) -____~~ 
(1) Stripped 0.178 2.50 0.337 2.80 0.159 
(2) + NaClO.15 M 0.782 2.70 0.969 2.90 0.187 
(3) + DPG 1.176 2.81 1.34 2.90 0.164 
(4) + NaClO.15 M + DPG 1.042 2.70 1.305 2.87 0.263 
a Conditions: (1) bis-Tris 0.02 M, [NaCl] 0.005 M; (2) bis-Tris 0.05 M, [NaCI] 0.150 M; (3) as 
in (1) plus [DPG Na,] 5 mol/mol Hb,; (4) as in (2) plus [DPG] 5 mol/mol Hb,. In all instances 
[EDTA] 1O-6 M, [Hb,] 3 X lo-’ M (tetramer), pH 7.0, T 25°C 
hemoglobins A and TG had identical alkaline Bohr 
effects (AlogPs,,/ApH = -0.28). Table 3 shows com- 
parative values for log Pse, Hill coefticient n, of both 
hemoglobins and their interactions with anions, at 
pH 7 .O. The AlogPso column indicates that HbTG 
retained its high 02 affinity relative to HbA whether 
in the presence or absence of chloride or DPG. This 
demonstrates also normal interactions of HbTG with 
anions. The larger AlogP5e observed in the presence 
of both DPG and chloride may indicate however a 
lower DPG binding to HbTG in these conditions. 
4. Discussion 
HbTG was discovered in a symptom free patients 
and in one of his daughters, the second member of 
the family carrying the abnormal Hb. The amount of 
the abnormal component in the erythrocytes was 
estimated to approx. 40% This is a new case of an 
electrophoretically silent Hb variant uncovered by 
both recording the O2 binding curve and isoelectro- 
focusing. Its main interest comes from both the loca- 
tion of the abnormality and from its functional prop- 
erties. The substitution of Gln for Pro at the /3 124 
(Ha) is interesting as this residue is invariant in all the 
human (Y and non-o chains which have been sequenced 
except in embryonic { chains where it is replaced by 
Ile [ 171. Only one other mutation has been described 
for this residue, Hb Khartoum or cw& 124 (Hz) 
Pro + Asp but unfortunately without functional 
studies [S]. Despite the substitution of a Pro at the 
cur/I, contact HbTG is not unstable and it is noticeable 
that its physiological consequence is an increase of 
April 1978 
the erythrocyte mass which is at variance with two 
other or/I1 Hb variants, Hb Tarrant [ 181 and Hb 
Philly [4] where the increased 0, affinity is accom- 
panied by hemolytic anemia. HbTG is also unique 
among abnormal Hb at the q,flr contact in that it has 
a moderately increased O2 affinity (P5e HbTG/PsO 
HbA = 0.7) normal cooperativity, normal alkaline 
.Bohr effect and almost normal interactions with 
anionic effecters. Such features are not usually described 
in Hb variants at the cur/3r contact but have been 
reported in a large variety of Hb variants either cr 
mutants such as Hb Broussais [ 191, Fort de France 
[20], Sawara 1211 or p mutants such as Hb Brigham 
[22], Little Rock [23], Hsi-Tsou or Szuhu [24]. Any 
molecular explanation for the high O2 affinity of 
stripped HbTG will demand further studies. One may 
postulate that due to a change in polarity of Gln 
relative to Pro and/or of its charge, the substitution 
may weaken the contact between the H helix and the 
opposing /3 helix of the OL chain, thus favouring a more 
R-like structure by narrowing the central cavity 
between the two /3 chains. This is suggested by the 
difference in DPG binding to HbTG in the presence of 
chloride. 
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